[en] Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer (NSCLC). Identifying pathological nodal (N2) disease is, however, of great importance because its presence significantly affects outcomes and potential treatment strategies. Recent data supporting the use of adjuvant or neoadjuvant therapies in these patients suggests that every reasonable effort should be made to assess the lymph node status accurately in patients with clinical early stage disease as well as in those with clinically staged N2 disease who have undergone preoperative treatments. Newer procedures such as integrated positron emission tomography computed tomography and esophageal or endobronchial endoscopic ultrasound with fine needle aspiration are mininially invasive techniques that may enhance the accuracy of mediastinal staging, traditionally devoted to mediastinoscopy. As their availability widens, they are likely to become an important part of staging and treatment paradigms. Intraoperatively, a growing body of evidence Suggests that lymph node dissection can be performed safely, and should replace sampling as a more effective means of identifying unsuspected N2 disease. This paper will review the current literature on staging NSCLC with regard to the detection of I nodal disease through preoperative staging of the mediastinum, the use of intraoperative lymph node sampling or dissection at the time of resection, and procedures for use in restaging patients with clinical stage IIIA N2 disease who have undergone preoperative chemotherapy (with or without radiotherapy).
Disciplines :
Oncology Cardiovascular & respiratory systems
Author, co-author :
Kim, E. S.
Bosquee, Léon ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Language :
English
Title :
The importance of accurate lymph node staging in early and locally advanced non-small cell lung cancer: An update on available techniques
Publication date :
June 2007
Journal title :
Journal of Thoracic Oncology
ISSN :
1556-0864
eISSN :
1556-1380
Publisher :
Lippincott Williams & Wilkins, Philadelphia, United States - Pennsylvania
Herder, G.J.M., Verboom, P., Smit, E.F., Practice, efficacy and cost of staging suspected non-small cell lung cancer: A retrospective study in two Dutch hospitals (2002) Thorax, 57, pp. 11-14
Van Tinteren, H., Hoekstra, O.S., Smit, E.F., Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial (2002) Lancet, 359, pp. 1388-1393
Mountain, C.F., Revisions in the international system for staging lung cancer (1997) Chest, 111, pp. 1710-1717
Detterbeck, F.C., DeCamp, M.M., Kohman, L.J., Invasive staging: The guidelines (2003) Chest, 123, pp. 167-175
Felip, E., Stahel, R.A., Pavlidis, N., ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC) (2005) Ann Oncol, 16 (SUPPL. 1), pp. i28-i29
Clinical practice guidelines in oncology (2006) Non-small cell lung cancer, , http://www.nccn.org/ professionals/physician_gls/PDF/nscl.pdf.v.2.2006, National Comprehensive Cancer Network, Available at:, Accessed: 25 August
Silvestri, G.A., Tanoue, L.T., Margolis, M.L., The noninvasive staging of non-small cell lung cancer: The guidelines (2003) Chest, 123, pp. 147-156
Reed, C.E., Harpole, D.H., Posther, K.E., Results of the American College of Surgeons Oncology Group Z0050 Trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer (2003) J Thorac Cardiovasc Surg, 126, pp. 1943-1951
Douillard, J., Rosell, R., Delena, M., Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial (2006) Lancet Oncol, 7, pp. 719-727
Betticher, D.C., Hsu Schmitz, S.F., Totsch, M., Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: A multicenter phase II trial (2003) J Clin Oncol, 21, pp. 1752-1759
Betticher, D.C., Hsu Schmitz, S.F., Totsch, M., Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study (2006) Br J Cancer, 94, pp. 1099-1106
(2007) Cisplatin and docetaxel with or without radiation therapy in treating patients who are undergoing surgery for newly diagnosed stage III non-small cell lung cancer. 2006, , http://www.clinicaltrials.gov/ct/show/NCT00113386?order=1, Radiation Therapy Oncology Group, Available at:, Accessed: March
(2007) Chemotherapy with or without radiation therapy before surgery in treating patients with stage IIIA non-small cell lung cancer. 2006, , http://www.clinicaltrials.gov/ct/show/ NCT00030771?order=1, Swiss Institute for Applied Cancer Research, Available at:, Accessed: March
Toloza, E.M., Harpole, L., McCrory, D.C., Noninvasive staging of non-small cell lung cancer: A review of the current evidence (2003) Chest, 123 (1 SUPPL.), pp. 137S-146S
Sachs S, Bilfinger TV, Komaroff E, Franceschi D. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer. Clin Lung Cancer 2005
6:310-313
Dhital, K., Saunders, C.A., Seed, P.T., (18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer (2000) Eur J Cardiothorac Surg, 18, pp. 425-428
Jeong, H.J., Min, J.J., Park, J.M., Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer (2002) Nucl Med Commun, 23, pp. 865-870
Vansteenkiste, J.F., Stroobants, S.G., Dupont, P.J., Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group (1999) J Clin Oncol, 17, pp. 3201-3206
Lardinois, D., Weder, W., Hany, T.F., Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography (2003) N Engl J Med, 348, pp. 2500-2507
Cerfolio, R.J., Bryant, A.S., Ojha, B., Eloubeidi, M., Improving the inaccuracies of clinical staging of patients with NSCLC: A prospective trial (2005) Ann Thorac Surg, 80, pp. 1207-1214
Cerfolio, R.J., Ojha, B., Bryant, A.S., (2004) Ann Thorac Surg, 78, pp. 1017-1023. , The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer
Hürtgen, M., Friedel, G., Toomes, H., Fritz, P., Radical video-assisted mediastinoscopic lymphadenectomy (VAMLA) - technique and first results (2002) Eur J Cardiothorac Surg, 21, pp. 348-351
Leschber, G., Holinka, G., Linder, A., Video-assisted mediastinoscopic lymphadenectomy (VAMLA) - a method for systematic mediastinal lymphnode dissection (2003) Eur J Cardiothorac Surg, 24, pp. 192-195
Witte, B., Wolf, M., Huertgen, M., Video-assisted mediastinoscopic surgery: Clinical fesibility and accuracy of mediastinal lymph node staging (2006) Ann Thorac Surg, 82, pp. 1821-1827
Kuzdzal, J., Zielinski, M., Papla, B., Transcervical extended mediastinal lymphadenectomy-the new operative technique and early results in lung cancer staging (2005) Eur J Cardiothorac Surg, 27, pp. 384-390
Kuzdzal, J., Zielinski, M., Papla, B., The transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non-small cell lung cancer staging (2007) Eur J Cardiothorac Surg, 31, pp. 88-94
Annema, J.T., Versteegh, M.I., Veselic, M., Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer (2005) JAMA, 294, pp. 931-936
Larsen, S.S., Vilmann, P., Krasnik, M., Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: Preliminary results from a randomised clinical trial (2005) Lung Cancer, 49, pp. 377-385
Eloubeidi, M.A., Cerfolio, R.J., Chen, V.K., Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans (2005) Ann Thorac Surg, 79, pp. 263-268
Yasufuku, K., Chiyo, M., Sekine, Y., Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes (2004) Chest, 126, pp. 122-128
Rintoul, R.C., Skwarski, K.M., Murchison, J.T., Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging (2005) Eur Respir J, 25, pp. 416-421
Yasufuku, K., Chiyo, M., Koh, E., Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer (2005) Lung Cancer, 50, pp. 347-354
Herth, F.J., Ernst, A., Eberhardt, R., Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum (2006) Eur Respir J, 28, pp. 910-914
Vilmann, P., Krasnik, M., Larsen, S.S., Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy: A combined approach in the evaluation of mediastinal lesions (2005) Endoscopy, 37, pp. 833-839
Patelli, M., Agli, L.L., Poletti, V., Role of fiberscopic transbronchial needle aspiration in the staging of N2 disease due to non-small cell lung cancer (2002) Ann Thorac Surg, 73, pp. 407-411
Massard, G., Ducrocq, X., Kochetkova, E.A., Sampling or node dissection for intraoperative staging of lung cancer: A multicentric cross-sectional study (2006) Eur J Cardiothorac Surg, 30, pp. 164-167
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials (1995) BMJ, 311, pp. 899-909. , Non-small Cell Lung Cancer Collaborative Group
Arriagada, R., Bergman, B., Dunant, A., Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer (2004) N Engl J Med, 350, pp. 351-360
Kato, H., Ichinose, Y., Ohta, M., A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung (2004) N Engl J Med, 350, pp. 1713-1721
Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633. ASCO Annual Meeting Proceedings Part I. 24 (June 20 Supplement). J Clin Oncol 2006
7007
Winton, T.L., Livingston, R., Johnson, D., A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10 [Abstract 7018] (2004) Proc Am Soc Clin Oncol, 22. , 621s
Scagliotti GV, Fossati R, Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst 2003
95:1453-1461
Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients. ASCO Annual Meeting Proceedings Part I. 24 (June 20 Supplement). J Clin Oncol 2006
7008
Allen, M.S., Darling, G.E., Pechet, T.T.V., Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial (2006) Ann Thorac Surg, 81, pp. 1013-1020
Wu, Y., Huang, Z.F., Wang, S.Y., A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer (2002) Lung Cancer, 36, pp. 1-6
Stamatis, G., Fechner, S., Hillejan, L., Repeat mediastinoscopy as a restaging procedure (2005) Pneumologie, 59, pp. 862-866
Jaklitsch MT, Gu L, Harpole DH, et al. Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): results of CALGB 39803. ASCO Annual Meeting Proceedings. 23 (June 1 Supplement). J Clin Oncol 2005
7065
De Leyn, P., Stroobants, S., De Wever, W., Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer: A Leuven Lung Cancer Group study (2006) J Clin Oncol, 24, pp. 3333-3339
Mateu-Navarro, M., Rami-Porta, R., Bastus-Piulats, R., Remediastinoscopy after induction chemotherapy in non-small cell lung cancer (2000) Ann Thorac Surg, 70, pp. 391-395
Van Schil, P., van der Schoot, J., Poniewierski, J., Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer (2002) Lung Cancer, 37, pp. 281-285
De Waele, M., Hendriks, J., Lauwers, P., Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy (2006) Eur J Cardiothorac Surg, 29, pp. 240-243
Cerfolio, R.J., Bryant, A.S., Ojha, B., Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: A prospective study (2006) J Thorac Cardiovasc Surg, 131, pp. 1229-1235